Tranexamic Acid in Traumatic Brain Injury

• Status: Not yet recruiting
• Trial end date: 2023-10-15
• Target enrollment: 0
• Participant gender: All

Summary

In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Isolated traumatic brain injury patients (mild or moderate cases)

• GCS > 8

• non penetrating TBI in 8 hours onset

• Age ≥ 18 years

Exclusion Criteria:

• Patient in cardiac arrest

• Patients with coagulopathies

• Renal failure patients

• pregnancy

• Patient refusal to participate